Newsletter | July 1, 2025

07.01.25 -- 2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs

CLINICAL TRIAL TECHNOLOGY

2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs

GRIN Therapeutics CEO Bruce Leuchter, MD, explores how integrating new business models and technological advances will be crucial to developing new treatments for rare neurological disorders.

Deriving Reliable Clinical Outcome Scores From Continuous DHT Data

DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.

Solving Key eCOA Challenges Through Digital Trials—Proof Points!

Medable has reached some important milestones and shares them in its end-of-year report. Check it out to see what game-changing results they've brought to their customers.

Feasibility Insights In NSCLC With EGFR Mutations

Discover how the sponsor of a NSCLC trial targeting EGFR mutations leveraged customizable simulation tools to forecast enrollment timelines, mitigate site-level risks, and more.

Transforming Medical Data Into Research Insights

Discover the efficiency and security of automated, precise source data capture.

SURVEY

Have you outsourced in clinical trials?

Tell Clinical Leader how we can better support you in finding the right partners. 

 

Share your thoughts here.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial Technology. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: